
|Articles|October 27, 2021
Pharmacy Clinical Pearl of the Day: Breast Cancer
Author(s)Saro Arakelians, PharmD
After skin cancer, breast cancer is the most common cancer diagnosed in women in the United States.
Advertisement
Clinical Pearl of the Day: Breast Cancer
Breast cancer is a cancer that forms in the cells of the breasts.
Insight:
- After skin cancer, breast cancer is the most common cancer diagnosed in women in the United States.
- Breast cancer can occur in both men and women, but it's far more common in women.
- Symptoms include a breast lump or thickening that feels different; change in the size, shape, or appearance of the breast; a newly inverted nipple; peeling, scaling, crusting or flaking of the pigmented area of skin; and redness or pitting of the skin.
- Risk factors include being female, increasing age, history of breast cancer, family history, obesity, and having a child at an older age.
- Diagnostic tools may include breast exam, mammogram, breast ultrasound, biopsy, and MRI.
- Treatment includes lumpectomy, mastectomy, sentinel node biopsy, axillary lymph node dissection, radiation therapy, chemotherapy, hormone therapy, targeted drug therapy, immunotherapy, and palliative care.
- Chemotherapy can be given before surgery (neoadjuvant) or after surgery (adjuvant).
- Adjuvant and neo-adjuvant drug may include anthracyclines, such as doxorubicin (Adriamycin), epirubicin (Ellence); taxanes such as paclitaxel (Taxol) and docetaxel (Taxotere), 5-Fluorouracil (5-FU) or capecitabine, cyclophosphamide (Cytoxan), and carboplatin.
Sources:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
2
ADA 2026: Factors Associated With GLP-1 RA Nonresponse in T2D—and What Pharmacists Should Screen For
3
ADA 2026: Optimized Inhaled Insulin Dosing Outperforms Subcutaneous Analogs for Postprandial Glucose in T1D
4
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
5






































































































































